MiMedx Planning U.S. Launch for Ambient Temperature Version of OrthoFlo
MiMedx is planning a U.S. launch for a next-generation lyophilized version of OrthoFlo, its amniotic fluid-based allograft for use in in...
MiMedx is planning a U.S. launch for a next-generation lyophilized version of OrthoFlo, its amniotic fluid-based allograft for use in in...
Study results suggest that AMNIOX Medical’s CLARIX®  FLO and CLARIX® CORD 1K regenerative therapies improved outcomes in plantar fasciitis treatment and tarsal coalition repair....
Medtronic launched the Pivox™ Oblique Lateral Spinal System with Lateral Plate for OLIF25™ and the Divergence-L™ Anterior/Oblique Lumbar Fusion System for...
Graftys was granted U.S. Patent No. 13/923,577, covering GRFT-R02 highly-osteogenic biomaterial for use in bone tissue regeneration....
Preclinical data on adipose-derived mesenchymal stem cells in a rat model, using technology similar to AlloSource’s AlloStem® Cellular Bone Allograft process, showed bone...
Cartiva received FDA Premarket Approval for the Synthetic Cartilage Implant to treat arthritis of the great toe. Product introduction will occur...
Cytori Therapeutics announced approval for Cytori Cell Therapy™ under the Japanese Act on the Safety of Regenerative Medicine. ...
Carmell Therapeutics received U.S. Patent No. 9,364,503, broadly covering the use of plasma-based materials to deliver drugs and proteins to an injured site....
AlloSource launched AlloFuse® Cortical Fibers and AlloFuse Fiber Boat demineralized cortical fiber allografts for a variety of spine and orthopaedic procedures. ...
Avitus Orthopaedics launched pilot sales of the Avitusâ„¢ Bone Harvester....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.